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The NetherlandsA B S T R A C TObjectives: To describe the research that has been undertaken by
the EuroQol Group to improve current methods for health state
valuation, to summarize the results of an extensive international
pilot program, and to outline the key elements of the ﬁve-level
EuroQol ﬁve-dimensional (EQ-5D-5L) questionnaire valuation proto-
col, which is the culmination of that work. Methods: To improve on
methods of health state valuation for the EQ-5D-5L questionnaire,
we investigated the performance of different variants of time trade-
off and discrete choice tasks in a multinational setting. We also
investigated the effect of three modes of administration on health
state valuation: group interviews, online self-completion, and face-
to-face interviews. Results: The research program provided the basis
for the EQ-5D-5L questionnaire valuation protocol. Two different
types of tasks are included to derive preferences: a newly developed
composite time trade-off task and a forced-choice paired compar-
isons discrete choice task. Furthermore, standardized blockedt & 2014, International Society for Pharmacoecon
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Open access under CC BY-NC-ND license.designs for the selection of the states to be valued by participants
were created and implemented together with all other elements of
the valuation protocol in a digital aid, the EuroQol Valuation
Technology, which was developed in conjunction with the protocol.
Conclusions: The EuroQol Group has developed a standard protocol,
with accompanying digital aid and interviewer training materials,
that can be used to create value sets for the EQ-5D-5L questionnaire.
The use of a well-described, consistent protocol across all countries
enhances the comparability of value sets between countries, and
allows the exploration of the inﬂuence of cultural and other factors
on health state values.
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In the literature, the validity and reliability of the standard
three-level EuroQol ﬁve-dimensional (EQ-5D-3L) questionnaire
in many disease areas has been well documented (see, e.g.,
[1,2]). The EQ-5D-3L questionnaire has been shown to be a
discriminative and evaluative measure in many conditions and
has also been used in population health measurement. Some
have argued, however, that generic measures such as the EQ-
5D questionnaire may lack sensitivity or fail to capture impor-
tant aspects of health in certain disease areas. These limita-
tions could be attributed to the descriptive system, that is, the
health dimensions and/or number of levels within each dimen-
sion, or the scoring algorithm. To address the issue of sensi-
tivity, the EuroQol Group has undertaken an ambitiousresearch and development program that aimed at the develop-
ment of a more sensitive health status measurement
instrument.
As a ﬁrst step, the Group has developed the EQ-5D-5L ques-
tionnaire in which the number of levels in each dimension of the
standard EQ-5D questionnaire is increased from three to ﬁve. The
EQ-5D-5L questionnaire retains the original ﬁve dimensions but
has modiﬁed the descriptive system to a ﬁve-level classiﬁcation
of severity: no problems, slight problems, moderate problems,
severe problems, and extreme problems [3]. The EQ-5D-5L ques-
tionnaire describes 3125 (55) unique states compared with 243 (35)
described by the EQ-5D-3L questionnaire.
Parallel ﬁelding of the EQ-5D-5L questionnaire and the EQ-5D-
3L questionnaire has provided a mapping algorithm between the
two instruments, allowing EQ-5D-5L questionnaire states to beomics and Outcomes Research (ISPOR).
nology Assessment, Institute of Health Policy and Management,
he Netherlands.
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[4]. This provides an interim solution to value EQ-5D-5L ques-
tionnaire states. Of course, this solution has its limitations.
Structurally, a value set based on preferences elicited speciﬁcally
for the instrument is required. Value sets for the EQ-5D-3L
questionnaire were mainly (although not exclusively) based on
time trade-off (TTO) methods [5]. The TTO is, however, a complex
valuation technique. The EuroQol Group has decided to explore
the potential of a recently introduced valuation method in this
ﬁeld, namely, discrete choice (DC) modeling. The purpose is to
explore whether this method can provide additional information
to supplement the TTO values [6]. Furthermore, the conventional
approach to TTO is known to have some important problems,
particularly relating to the way values are obtained for health
states considered to be worse than dead (i.e., values o0) [7,8]. For
example, the conventional TTO uses conceptually different
approaches to the valuation of states better than dead and worse
than dead, resulting in arbitrarily large negative values. Tradi-
tionally, this has been redressed by a transformation of the
negative values to a range with a minimum of 1 [7,8]. To
address the issues, the EuroQol Group initiated a program of
methodological research to develop new methods for TTO. Multi-
ple variants of the “lead-time” and “lag-time” TTO [9–12] were
investigated. The methodological research program also included
experiments in the use of DC as a means of valuing EQ-5D
questionnaire states [6].
On the basis of earlier methodological research, a draft
protocol was developed to be tested and adapted after a multi-
national piloting program. A key objective of the pilot projects
has been to test out variants of the interview in an international
context and to adapt the methodology on the basis of the insights
gained. The resulting protocol can be implemented in future EQ-
5D-5L questionnaire valuation studies uniformly across different
countries. A digital aid has been developed to implement the
study design using the same valuation methods and protocol for
data collection. This standardization will allow research teams
engaging in valuation studies of the EQ-5D-5L questionnaire
to produce results at a high level of quality control and
comparability.
The aim of this article was to describe the international
research conducted by the EuroQol Group to improve the meth-
ods for health state valuation, to summarize the results of an
extensive international pilot program, and to outline the key
elements of the EQ-5D-5L questionnaire valuation protocol,
which is the culmination of that work. Because of the sheer
volume of work presented in this article, we describe only the
most important and relevant ﬁndings of the piloting program in
this article. More detailed information on many aspects of the
studies summarized here can be found in a forthcoming supple-
ment [13].ig. 1 – Iteration sequence for 10-year lead-time þ 5-year disease
TO task (lead time þ disease time). TTO, time trade-off.Methods
Tasks
Time trade-off
The conventional TTO establishes the value for a health state by
locating the amount of time in full health x, which is considered
equal in utility terms to a given amount of time in a poor health
state t, and calculating the value of the state as x/t. In EQ-5D
questionnaire valuation studies, t is generally set (by convention)
at 10 years. This approach has been widely used in valuation
studies of the EQ-5D-3L questionnaire and works well to elicit
values for states that are considered to be better than dead (i.e.,
have values between 0 and 1). The conventional TTO approach to
eliciting values less than 0, however, is problematic. One means
of avoiding the problems associated with the conventional
approach to eliciting values less than 0 is to simply provide more
“trading time” in full health so that when valuing very poor states
of health, respondents can trade off more time. The additional
trading time can be added either before the health state being
evaluated (a “lead-time TTO”) or after the state being evaluated (a
“lag-time TTO”) [9–12]. All TTO studies presented in this article
used an iterative sequence to allow respondents to arrive at their
points of indifference. The iteration sequence that was used in
the main study is shown in Figure 1.DC modeling
There has been renewed interest recently in ordinal response
methods in estimating quality-of-life weights for various instru-
ments [6,14–16]. Several empirical studies analyzing ordinal
response data to infer latent cardinal values of the EQ-5D
questionnaire have been reported in recent years [6,17–19].
Methods for collecting ordinal responses fall into the methodo-
logical tradition of DC analysis. The EuroQol Group started to
explore the use of DC modeling as a valuation technique for the
EQ-5D questionnaire in 2008 with a pilot study carried out in The
Netherlands [6]. It was found that DC values broadly replicated
the pattern found in TTO responses, although the DC values were
consistently slightly higher than TTO values. The main difﬁculty
in applying DC models was that these models generated values
on an arbitrary scale, not on the metric of the quality (of life)
component of the quality-adjusted life-year scale. This means
that DC-based values need to be anchored on the utility scale,
where full health has a value of 1 and dead has a value of 0. After
these initial ﬁndings, it was decided to include a DC task in the
pilot studies for the valuation of the EQ-5D-5L questionnaire to
further investigate the merits of DC for health state valuation.-time TTO. Numbers represent the total time shown in the
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Multinational study (core)
The ﬁrst pilot version of the valuation protocol for the EQ-5D-5L
questionnaire was implemented in four countries: Canada, Eng-
land, The Netherlands, and the United States (Table 1). This study
consisted of a DC task with a design of 200 pairs (forced choice
paired comparison of 2 EQ-5D-5L questionnaire states), a visual
analogue scale (VAS) valuation task for the 400 states included in
the 200 DC pairs, and a lead-time TTO task with 100 states (10-
year lead-time duration and 5-year disease time duration). We
used a blocked study design with 20 blocks so that each
respondent would answer 10 DCs, 20 VASs, and 5 lead-time
TTOs. The design for the DC and VAS was based on the Bayesian
efﬁcient design algorithm also used in the EQ-5D-3L question-
naire pilot study [6]. The design for the TTO task was created
using Fedorov’s exchange algorithm [20,21]. The sample size was
400 respondents for each of the four countries, totaling 1600 and
leading to 80 observations per DC pair, per VAS state, and per
TTO state. The experimental design was considered to result in
adequate power. We used general population samples in all pilot
studies. Given the pilot nature of the work, a formal sampling
framework was not used, but respondents were selected in such
a way that the study samples were broadly representative of the
country populations with respect to age and sex (Table 1).
Multinational study (experimental elements)
The core study was extended to Argentina, China, Singapore, and
Spain (Table 1). In the ﬁrst three countries, experiments relating to
the TTO task were included in the study; in the fourth country, an
experiment with DC was included in the study. The initial choice
for using the lead-time TTO as the prime TTO candidate was to a
certain degree arbitrary. The EuroQol Group has more experience
with lead-time TTO than with lag-time TTO. To make a more
informed decision regarding this choice, the Argentina study
contained an experiment to compare lead-time TTO and lag-
time TTO. Also, the lead-time TTO approach might be susceptible
to framing effects relating to the ratio of lead time to disease time
[11]. Therefore, the Chinese study contained an experiment with
5-year lead-time and 5-year disease-time duration. Furthermore,
the lead-time TTO might suffer from a framing effect relating to
respondents’ awareness of the distinction between the lead-time
part (indicating the state is considered to be worse than dead) and
the disease-time part (indicating the state is better than dead). To
investigate this, the Singapore study contained an experiment in
which the time window for the disease time and the lead time
were separated more strongly in the visual display. All three
studies used a split sample design in which half the respondents
got the TTO task from the core study and half the respondents got
the experimental TTO task. A subset of 10 states from the 100
state TTO designs of the core study was used in the TTO experi-
ments. The 10 states were manually chosen so that they covered
the entire utility range: 21111, 11221, 12112, 33133, 52221, 44113,
52324, 55523, 11145, 53555. The Spanish study included a DC
experiment in which the paired comparisons between health
states were complemented with comparisons between each
health state included in the pairs and being dead. This allows
the DC model to be anchored on the utility scale without the need
of anchoring the DC model on TTO data [6,22]. However, the
appropriateness of the model used for this analysis has been
debated in the literature because respondents who prefer any
state to death violate the assumptions underlying the DC frame-
work [23]. An efﬁcient subset of 50 pairs from the 200 pair design
of the core study was generated with the Bayesian efﬁcient design
algorithm. The sample size was N ¼ 400 for all four studies,
resulting in 100 observations per study arm per state for the TTO
experiments and 80 observations per pair for the DC experiment.Follow-up study 1: Comparing TTO variants via an Internet
panel
A follow-up study was undertaken in The Netherlands in the fall
of 2011 to compare six different TTO tasks (Table 1). These were
the conventional TTO, two variants of lag-time TTO (lag-time to
disease-time ratios of 10 to 5 years and 10 to 10 years), and two
variants of the lead-time TTO (lead-time to disease-time ratios of
10 to 5 years and 10 to 10 years). The sixth TTO task was also a
lead-time TTO with a ratio of 10 to 5 years, but using an adapted
iteration sequence to guide the respondents to their point of
indifference. In addition to the TTO tasks, respondents got either
a DC task or a case 2 best-worst scaling task (the latter is not
presented in this article). The 100 state TTO design and 200 pair
(400 state) DC design from the core study were used. The total
sample size was N ¼ 5000, or between 800 and 1000 respondents
for each of the six TTO tasks. This implied between 40 and 50
observations per TTO state, which resulted in sufﬁcient power for
comparison of the six TTO tasks.
Follow-up study 2: Feasibility of composite TTO
A second follow-up study was undertaken in 2011 in The Nether-
lands to test the feasibility of the composite TTO approach
(Table 1). This new type of TTO was implemented on the basis
of our experiences from the previous pilot studies. In the compo-
site TTO, values for states better than dead are elicited using the
conventional TTO approach with a 10-year time frame, while
values for states worse than dead are elicited using the lead-time
TTO with a ratio of lead time to disease time of 1:1, that is, 10
years lead time and 10 years in the state to be valued. The 10
states selected to be valued in this study were the same as those
in the TTO experiments of the multinational study. The sample
size was N ¼ 120, and each respondent valued all 10 states.
Data Collection Setting
In seven of the eight countries in the multinational study, data
were collected in a group interview setting using respondents
from marketing agencies. Respondents were asked to come to
one of several alternative central locations. Instructions were
then provided by trained interviewers to groups of 10 to 15
respondents, after which each respondent answered the ques-
tions in the interview. Interview assistance was available to
answer respondents’ questions and give support. In one country
(England), the interview setting was changed to face-to-face
interviews at the respondents’ homes. For data collection in the
ﬁrst follow-up study, an existing online Internet panel was used.
In the second follow-up study, to establish the feasibility of
composite TTO, a face-to-face interviewer setting was used. The
respondents for these interviews were asked by a marketing
agency to come to a single central location where the interviews
were conducted.
Valuation Technology
It is envisaged that the EQ-5D-5L questionnaire will be used in
many different countries as is the case for the EQ-5D-3L ques-
tionnaire. Therefore, it is important that the valuation protocol
can also be used internationally. The pilot valuation protocol was
implemented in a digital setting from the start to make stand-
ardization of the protocol for the different experiments and
different languages more feasible. The pilot studies were carried
out by using the digital aid in which the pilot valuation protocol
was embedded. The digital setting used a computer-assisted
personal interview mode of administration: the EuroQol Valu-
ation Technology (EQ-VT). The advantage of using a digital aid
compared with more traditional pen-and-paper type “props” is
that it forces interviewers to follow the same procedures, thereby
Table 1 – Overview of the EQ-5D-5L questionnaire valuation experiments.
Study
Multinational study: Core Multinational study: Experiments Follow-up
study 1
Follow-up
study 2
Country The
Netherlands
England United
States
Canada Argentina China Singapore Spain The
Netherlands
The
Netherlands
Data
collection
period
December
2010
January
2011
May 2011 May 2011 June 2011 June 2011 June 2011 June 2011 September
2011
November
2011
Setting Group
interview
1 on 1
interview
Group
interview
Group
interview
Group
interview
Group
interview
Group
interview
Group
interview
Internet survey 1 on 1
interview
Valuation
tasks
DC, VAS, TTO DC, VAS,
TTO
DC, VAS,
TTO
DC, VAS,
TTO
DC, VAS,
TTO
DC, VAS,
TTO
DC, VAS,
TTO
DC, TTO BWS, DC, TTO TTO
TTO variant 10-5 lead time 10-5 lead
time
10-5 lead
time
10-5 lead
time
5-10 lag
time
5-5 lead
time
10-5 lead
time
10-5 lead
time
10-5 lead time Composite
TTO:
10-5 lead
time
10-5 lead
time
10-10 lead time BTD classic
10-y TTO
5-10 lag time WTD 10-10
lead time
10-10 lag time
Classic 10-y
TTO
10-5 lead time
different
iteration
procedure
DC variant Standard Standard Standard Standard Standard Standard Standard DC þ dead Standard –
Layout EQ-VT Standard Standard Standard Standard Standard Standard Framing
effect
Standard Standard Composite
TTO
N states TTO 100 100 100 100 10 10 10 100 100 10
N pairs DC 200 200 200 200 200 200 200 50 200 –
N respondents 400 400 400 400 400 400 400 400 5000 120
% men 49 50 51 42 47 47 48 41 42 56
% age 18–35 y 30 57 45 48 47 53 47 35 33 36
% age 36–54 y 50 32 34 29 36 42 46 36 44 43
% age 55þ y 20 12 21 24 17 4 7 29 24 21
BWS, best-worst scaling; BTD, better than dead task; DC, discrete choice; TTO, time trade-off; VAS, visual analogue scale; WTD, worse than dead task.
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V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 4 4 5 – 4 5 3 449reducing the probability of interviewer bias and eliminating data
entry and coding errors. All elements of the protocol are imple-
mented in the EQ-VT: assigning participants to sets of states from
the underlying blocked design, randomization procedures, the
iterative process in the TTO, and capturing and time stamping
the participants’ responses to all tasks. Different language ver-
sions of the EQ-VT were developed for which the same rigid
guidelines for the translation of the EQ-5D questionnaire itself
were used [24,25]. Last, the interviewer training materials were
also standardized and ofﬁcially translated.Results
Multinational Study (Core)
Mean lead-time TTO values ranged from 0.73 to 0.23. The
results of the multinational pilot study showed substantial
clustering at value 0 and value 1 (and to a lesser extent also at
1, 0.5, 0.6, and 0.8) (Fig. 2). Of these, the clustering at 0 for mild
and moderate states and at 1 for the severe states is counter-
intuitive because this implies that many respondents value mild
and moderate states as being as bad as dead and value severe-1.0
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Fig. 2 – Comparison of the TTO values obtained in the multinati
study. Observed proportion of responses for one mild state (121
for the EQ-5D-5L questionnaire. EQ-5D-5L, ﬁve-level EuroQol ﬁvstates as being equal to full health. To get an impression of the
response behavior of respondents, a cross-tabulation for all 100
TTO states included in the core part of the multinational study
was constructed (Fig. 3). In this chart, the rows indicate the
number of steps in the iteration sequence of the TTO taken by
respondents to come to their ﬁnal TTO answer. The columns
indicate the corresponding TTO values for each iterative step
(data from respondents using more than 20 iterative steps is
excluded from this ﬁgure). As can be seen, 75% of the observa-
tions are contained within the 27 cells with more than 50
observations each, and a further 10% of the observations are
contained in the 28 gray cells, containing between 20 and 50
observations each. This shows that most of the possible
responses and iteration paths are rarely (or not at all) used by
the respondents. In fact, 59% of all observations are distributed
over only six values: U ¼ 1, 0, 0.5, 0.6, 0.8, and 1 (6%, 19%, 10%,
6%, 6%, and 13%, respectively). Furthermore, many respondents
gave their answer after only one or two steps in the iteration
sequence (7% and 15%), indicating they “short-cut” the task.
Comparing the face-to-face interview setting used in England
with the group interview setting used in Canada, The Nether-
lands, and the United States, however, showed that the clustering
was less prominent (i.e.. lower) for the face-to-face interviews:Utility
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12), one moderate state (33133), and one severe state (53555)
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Fig. 3 – The number of steps in the iteration sequence made by the respondents (rows) versus the TTO-based utility value that
was given as a ﬁnal answer (columns). The ﬁgure shows the possible paths in the iteration sequence and how many
responses were given for each of the paths. For example, the cell on row 2 and column 0 (i.e., steps ¼ 2, utility ¼ 0) indicates
that in 1141 cases the point of indifference in the TTO task was reached at utility ¼ 0 and that this point was obtained after
two steps in the iteration sequence. The cell at (steps ¼ 9, utility ¼ 0) shows that 283 responses of utility ¼ 0 were obtained
after nine steps in the iteration sequence. Therefore, the same utility value was obtained but a different iteration path was
used. Arrows indicate the possible steps in the indifference procedure, white cells contain more than 50 observations, and
gray cells contain between 20 and 50 observations. TTO, time trade-off.
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number of answers given after one or two steps in the iteration
sequence. Because of the issues regarding the characteristics
and/or quality of the TTO data, we could not reliably estimate
and compare TTO models between countries.
To assess the performance of the DC task, we estimated and
compared main-effects models in each country. For each country,
we estimated a logit model with 20 dummy parameters (4
dummy variables for each of the ﬁve EQ-5D-5L questionnaire
dimensions). All the 20 parameters were statistically signiﬁcant,
except level 2 for Usual Activities in The Netherlands (P ¼ 0.55).
Only three modest illogical ordering of regression coefﬁcients
were observed. Predictions for the complete set of 3125 EQ-5D-5L
questionnaire states were quite similar for the four countries.
Correlations between the countries were high: from 0.88 (The
Netherlands vs. United States) through 0.97 (Canada vs. England).
Some comparisons of countries showed higher dispersions, in
particular between the values for The Netherlands and the
United States. The comparability between Canada versus England
and the United States was highest. Overall, the results from the
DC task in the multinational pilot study showed that respondents
were able to perform the task adequately in all countries as
shown by the consistency of the resulting DC models between
countries and attribute levels. Therefore, we decided to include
the DC task in the ﬁnal protocol.
Multinational Study (Experimental Elements)
Results from the Argentinean study showed that there were only
slight differences in the mean observed values elicited using
lead-time TTO and lag-time TTO and that the frequency distri-
butions of the TTO responses were very similar, both suffering
from similar levels of clustering as the core study (67% and 65%,
respectively, for the six values compared with 59% from the core).
These results did not provide enough evidence to establish
superiority of either lead-time TTO or lag-time TTO. The Chinese
study comparing lead-time TTO with a 10 to 5 ratio to that with a
5 to 5 ratio resulted in differences in the mean observed TTO
values but not in the level of clustering of the data (60% and 62%,
respectively, for the six values). In contrast, the split between the
lead-time bar and disease-time bar in the framing effect study inSingapore resulted in a higher degree of clustering (70% and 75%,
respectively, for the six values). Results from the Spanish DC
experiment are not reported here, but can be found elsewhere
[13].
Follow-Up Study 1: A Comparison of TTO Variants via an
Internet Panel
In this study, data were collected via Internet without the
presence of interviewers. This resulted in a worsening of the
response clustering compared with the core study; in particular,
the number of values ¼ 1 was much higher (Fig. 2). Generally, lag-
time TTO resulted in slightly lower values than did lead-time
TTO, while extending the time frame from 15 years to 20 years
resulted in slightly higher values for both lead-time TTO and lag-
time TTO (results not shown). Shortcutting of the TTO task was
more pronounced in the Internet study than in the core study:
26% of the respondents used one step in the iteration sequence
(U ¼ 1) and 20% used two steps (U ¼ 0), compared with 7% and
15%, respectively, in the core study. Last, the adapted iteration
procedure in the ﬁrst follow-up study did not resolve the
clustering of the data: clustering was still present, albeit at
different values.
Follow-Up Study 2: The Feasibility of Composite TTO
The results from these studies prompted us to revise the protocol
to address the data issues that were found. The results from the
different pilot studies clearly indicated that it is not feasible to
elicit TTO values in either a group interview setting or an online
setting. Also, the lead-time approach showed that apart from
theoretical beneﬁts, it produced results that showed that a large
proportion of respondents were using the complete time scale (i.
e., lead time plus disease time) to trade off, even for states that
evidently were not severe. This suggested that there would be
merit in using the conventional approach to TTO to obtain values
greater than 0, and introducing the lead-time TTO in which it
becomes apparent that the value is less than 0. The second
change was to deliberately opt for a face-to-face interview
setting. Therefore, in the composite TTO study, conventional
TTO was used to elicit values better than dead and lead-time TTO
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time was based on the fact that lead-time TTO is conceptually
(and in practical terms from the participants’ perspective) more
in line with the conventional TTO task and on the fact that lag
time was not shown to be superior to lead time. Because the time
frame for the conventional TTO was set at 10 years, it was
decided to use the lead-time TTO with a ratio of lead time to
disease time of 10 to 10 years for the elicitation of values worse
than dead. The results from the composite TTO study showed a
marked improvement in data quality (Fig. 2). For the mild EQ-5D-
5L questionnaire health state 12112, the clustering at U ¼ 0 is no
longer present and there are no values worse than dead. For the
moderate state 33133, the clustering at U ¼ 0 is almost completely
gone while the clustering at U ¼ 1 is markedly reduced. Again,
there were no values given for this state that were worse than
dead. For the severe state 53555, the clustering at U ¼ 1 is almost
completely absent, the clustering at U ¼ 0 is reduced, but a new
clustering appears at U ¼ 1. This pattern of responses is in line
with the expectations for such a severe health state.Fig. 4 – The composite TTO task. Conventional TTO with a
10-year time frame is used to value states better than dead,
and lead-time TTO with a time frame of 20 years is used to
value states worse than dead. TTO, time trade-off.EQ-5D-5L Questionnaire Valuation Protocol
Informed by the evidence from the multinational pilot studies,
the EuroQol Group decided on a standardized protocol for EQ-5D-
5L questionnaire value set studies. The protocol centers on
systematic approaches to collecting values for EQ-5D-5L ques-
tionnaire health states. The ﬁrst step in the valuation protocol
consists of welcoming the respondent and explaining the pur-
pose of the research he or she is taking part in (Table 2). Next,
respondents are asked to complete the EQ-5D-5L questionnaire
self-classiﬁer, the EQ-VAS, and background questions regarding
age, sex, and experience with illness. This introductory part is
then followed by the ﬁrst of the valuation tasks, the composite
TTO (Fig. 4). After an explanation of how to interpret and carry
out the composite TTO task, respondents are asked to evaluate 10
EQ-5D-5L questionnaire states, followed by three debrieﬁng
questions, for example, asking the respondents how difﬁcult
they found the composite TTO task. The respondents then
receive instructions on how to carry out the DC task and are
asked to complete seven paired comparisons (Fig. 5). This is thenTable 2 – Elements of the EQ-5D-5L valuation
protocol.
Start interview
1. General welcome
2. Introduction
a. Self reported health on the EQ-5D-5L descriptive system
b. Self reported health on the EQ-VAS
c. Background questions
3. Composite Time Trade-Off
a. Instructions and example of TTO task
b. TTO valuation of 10 EQ-5D-5L states
c. TTO debrieﬁng/structured feedback
4. Discrete Choice
a. Instructions and example of DC task
b. DC valuation of 10 pairs of EQ-5D-5L states
c. DC debrieﬁng/structured feedback
5. General thank you and goodbye
End interviewfollowed by three debrieﬁng questions regarding the DC task.
Last, the respondents are given an opportunity to comment on
the entire valuation exercise and are thanked for their
cooperation.Discussion
The protocol described in this article represents the culmination
of an ambitious program of research commissioned and coordi-
nated by the EuroQol Group over a 3-year period. This has
enabled us to make considerable progress in improving the
methods used to obtain TTO values; in complementing those by
using additional information on preferences obtained by DCs;
and in developing explicit study designs to underpin the selection
of states and tasks.
For the ﬁrst time, the EuroQol Group has developed a standard
protocol embedded in a digital aid and accompanied by inter-
viewer training materials, which can be made available to study
teams in countries wishing to develop local value sets for the EQ-
5D-5L questionnaire. Valuation studies have already been under-
taken for Canada, China, England, The Netherlands, and Spain.
More studies are in the process of development. The use of a
well-described, consistent protocol across all countries will ulti-
mately create a unique opportunity to compare health state
Fig. 5 – The discrete choice task, a forced choice paired
comparison of two EQ-5D-5L questionnaire health states.
EQ-5D-5L, ﬁve-level EuroQol ﬁve-dimensional.
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 4 4 5 – 4 5 3452preferences between countries and to explore the inﬂuence of
cultural and other differences on health state values.
A key methodological issue considered in the development of
this protocol was whether computer-based technology designed
to present the valuation tasks could replace the requirement
for face-to-face interviews by facilitating self-completion online
or in group-based settings. This would have the considerable
advantage of reducing costs and time involved in conducting
face-to-face interviews. Our research, however, clearly indicated
the importance of trained expert interviewers during TTO valu-
ation tasks, and this is likely to remain indispensable for TTO
tasks that involve a process of iteration toward indifference. Our
results correspond to those of Norman et al. [26] who also
observed clustering of values around U ¼ 1, U ¼ 0, and U ¼ 1
in an online TTO valuation study.
There is no “perfect” method for eliciting stated preferences
for health states: all methods have attendant advantages and
disadvantages, and inevitably choices between methods must
reﬂect judgments about these relative merits, given available
evidence. Inevitably, there remain methodological questions that
can be addressed in future research that might further improve
the valuation protocol. The composite TTO has improved the
means of eliciting values worse than dead and has removed the
need for arbitrary rescaling of values required by the conven-
tional TTO. This was accomplished by using the linear scale
restricted to 1 of the lead-time TTO, with a ratio of lead time to
disease time of 10 to 10 years. Research on the lead-time TTO
using different lead-time to disease-time ratios (reﬂected by
different lower bounds for the resulting utility scale) showed,
however, that the values worse than dead are affected by the
choice of this ratio. In other words, some participants considering
very severe states of health might want to trade off more time
than the maximum possible within the design of the composite
TTO task. Further research will be undertaken to explore meth-
ods that might be used to model these “censored” values [11].
Unresolved issues also remain for DC methods, such as
whether respondents use decision heuristics thereby violating
the DC model assumptions and the fact that for linear-in-
parameter models, the scaling factor φ and the parameter
estimates β cannot be estimated separately, but are estimated
as a ratio γ ¼ β/φ [27,28]. This means that β and φ are perfectly
confounded, which can bias the parameter estimates. This issue
is also known as variance heterogeneity [23]. Alternative formula-
tions of DC methods could improve the application of DC
methods for the quantiﬁcation of health states. These include
simply stating the duration that applies to all states; including
duration as an attribute to be varied within the design [23,29];
asking participants to state whether the states in the paired
comparisons are worse than being dead; or to identify the aspect
of each health state that is best and worst (i.e., case 2 best-worst
scaling) [30]. These approaches can potentially be used to providequantitative estimates of the utility associated with different
dimensions and levels of the EQ-5D-5L questionnaire and to
overcome the issue in DC of anchoring values at 0 and 1.
Experimentation in this area is continuing and may provide a
basis for future approaches to valuation.
There is an ongoing scientiﬁc debate on whether the scales on
which the elicited utilities are placed are true interval scales or
not, as is required by the quality-adjusted life-year model. In the
case of TTO, this is made apparent by the discussion on constant
proportional trade-offs [31,32]. It equally applies, however, to
other valuation techniques, including standard gamble and DC.
For the ﬁrst time, the EuroQol Group has developed a standard
protocol with accompanying digital aid and interviewer training
materials to elicit values for the EQ-5D-5L questionnaire. The use
of a well described, consistent protocol across all countries
enhances the comparability of value sets between countries,
and allows the exploration of inﬂuence of cultural and other
differences on health state values. Researchers interested in
undertaking a valuation study for the EQ-5D-5L questionnaire
using the EQ-VT can contact the EuroQol Group (www.euroqol.
org) for further information on obtaining and using the EQ-VT.Acknowledgments
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